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A method has been established to sequentially delete combinations of genes from the ASFV genome to
test the effect on virus replication and host responses to infection. Initially the ASFV genes MGF505 2R
and MGF505 3R and a truncated MGF360 9L gene were deleted from the genome of the tissue-culture
adapted ASFV strain BA71V and replaced with bacteriophage loxP sequences ﬂanking the beta-
glucuronidase (GUS) marker gene to create recombinant virus VDMGF-GUS. Subsequently the GUS
gene was removed by site-speciﬁc recombination between the two loxP sites involving expression of
the bacteriophage Cre recombinase enzyme to create recombinant virus VDMGFDGUS. The EP402R and
EP153R genes were subsequently deleted from the genome of VDMGFDGUS, using the same GUS
marker gene, to construct virus VDMGFDCD2-Lectin-GUS. These sequential deletions of ASFV genes
were shown not to alter virus replication signiﬁcantly.
& 2012 Elsevier Inc. Open access under CC BY license.Introduction
ASFV causes a devastating haemorrhagic disease of domestic
pigs that was ﬁrst described in East Africa in the 1920s. The virus
is present in that region in a wildlife cycle involving warthogs and
soft ticks of the Ornithodoros species. In these hosts, the virus
causes persistent infections with few disease signs. The disease is
endemic in many sub-Saharan African countries and causes
sporadic outbreaks in others. Following its introduction to Georgia
in 2007, ASF has now spread extensively within the Russian
Federation and has been reported within 100 miles of the EU
border. Currently there is no vaccine available against ASFV.
Virulent isolates kill domestic pigs within 7–10 days of infec-
tion, with a mortality rate approaching 100%. However, less
virulent strains do not necessarily kill and recovered pigs can be
immune to subsequent challenge with related virulent viruses.
ASFV is a large, icosahedral, cytoplasmic virus and is the only
member of the family Asfarviridae (Dixon et al., 2005). The virus
has a linear double-stranded DNA genome varying from 170 kb to
194 kb depending on the isolate (Chapman et al., 2008, 2011; De
Villiers et al., 2010). The complete coding sequences of the Vero
cell-adapted strain, BA71V (Yanez et al., 1995), and of several high
and low virulence isolates of ASFV have been reported (Chapman
et al., 2008, 2011 and De Villiers et al., 2010). These reports have
identiﬁed genes that are not present in low virulence isolatesrams).
 BY license.compared to high virulence isolates including a sequence close to
the left genome end of about 8 kb containing six copies of
multigene family (MGF) 360 and two of MGF 505. Deletion of
these genes from the genome of a virulent isolate was shown to
result in increased production of type I interferon (Afonso et al.,
2004). The low virulence OURT88/3 isolate also has frame-shift
mutations in the EP402R and EP153R genes. These encode the
CD2v protein and C-type lectin protein, respectively (Chapman
et al., 2008). CD2v is required for the binding of red blood cells to
extracellular virus and infected cells (Rodriguez et al., 1993; Borca
et al., 1994). This protein has also been indicated to have a role in
the impairment of lymphocyte proliferation in response to mito-
gens (Borca et al., 1998). Expression of the C-type lectin protein
has been shown to inhibit up-regulation of cell surface expression
of MHC Class I molecules (Hurtado et al., 2011) but its deletion
does not affect virus growth in macrophages or virulence in swine
(Neilan et al., 1999; Galindo et al., 2000).
The role of ASFV encoded proteins has been investigated by
deletion of genes from the virus genome. In common with other
large DNA viruses, ASFV is known to encode several proteins
which target the same pathways. Therefore to investigate the role
of particular pathways in the virus interaction with its hosts, it
would be advantageous to delete several different genes.
Methods for making gene deletions within the ASFV genome
using homologous recombination to replace a speciﬁc gene with a
reporter gene were ﬁrst established by Rodriguez et al., 1992.
Subsequently the b-glucuronidase (GUS) gene was used as a
reporter to select recombinant ﬁeld isolates grown in primary
pig macrophages or COS-1 cells (Zsak et al., 1996). These methods
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individual genes DP71L, DP96R, CD2v and A238L or several
adjacent genes from virulent strains including Malawi LiL20/1,
E70 and Pr4. (Afonso et al., 1998; Zsak et al., 1998; Borca et al.,
1994 and Neilan et al., 1997). However, once the marker gene has
been inserted, this same marker gene cannot be used to make a
second deletion. In order to overcome this we used the bacter-
iophage cre/loxP recombination system to efﬁciently delete the
marker gene from a ﬁrst generation virus recombinant and
subsequently re-used the same marker gene to isolate a virus
gene deletion at a second locus.
The cre/loxP recombination system was ﬁrst discovered in the
bacteriophage P1 by Sternberg and Hamilton, 1981 and demon-
strated to operate in mammalian cells by Sauer and Henderson
1988. This system involves the speciﬁc deletion of a DNA
sequence located between two bacteriophage loxP sites and is
controlled by the bacteriophage Cre recombinase enzyme. Here
we describe the construction of transfer vectors containing loxP
sites ﬂanking the marker gene GUS under the control of the ASFV
B646L (VP72) gene promoter. Recombinant ASF viruses lacking
speciﬁc genes were obtained by insertion of this GUS marker gene
by homologous recombination to replace the genes of interest.
First generation recombinant viruses deleting a truncated copy of
the MGF 360 9L and the complete MGF505 2R and 3R genes were
isolated by screening for expression of GUS. Subsequently the
GUS marker gene was deleted using the Cre recombinase to
produce a second generation recombinant virus lacking the GUS
marker gene. The GUS marker gene ﬂanked by loxP sequences
was then reinserted into a second locus with the deletion of the
ASFV adjacent genes EP153R and EP402R to create a third
generation virus. Finally the GUS marker gene was deleted from
this virus using the cre/loxP recombination system.
This cre/loxP recombination system will enable sequential dele-
tion of genes from the ASFV genome to facilitate studies on their
individual protein functions. In addition, recombinant viruses con-
taining genes deleted in different combinations will allow us to
study the host response to potential new vaccines.loxPAFLANK  L
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Fig. 1. Schematic diagram showing generation of recombinant ASF viruses expressi
recombinase. First generation recombinant virus VDMGF-GUS was created by homolog
from genes MGF360 8L and MGF 505 4R on the wild type BA71V genome and transfer ve
and MGF505 genes 2R and 3R and the insertion of vp72GUS gene ﬂanked by loxP seq
control of the ASFV vp72 gene promoter was transfected into cells infected with VDMG
site-speciﬁc recombination between the two loxP sites resulting in deletion of the vp7
viral sequences A and B were included to facilitate the construction of plasmid pDMGResults and discussion
Deletion of the MGF505 2R and 3R genes and truncated MGF 360 9L
gene from the BA71V ASFV isolate
A transfer plasmid, pDMGFloxPGUS was constructed (see the
Materials and methods section) to enable the truncated MGF360
9L and MGF505 2R and MGF505 3R genes to be deleted from the
genome of the BA71V isolate by homologous recombination and be
replaced with the GUS gene (Fig. 1). This plasmid contained frag-
ments from the genes ﬂanking the deletion site; MGF360 8L to the
left and MGF505 4R to the right. It also included loxP sites ﬂanking
the GUS reporter gene under control of the ASFV B646L (vp72) late
gene promoter. The loxP sites were inserted to subsequently facilitate
excision of the GUS reporter gene from the ASFV genome using the
Cre recombinase protein. Short unique sequences, named A (21 bp)
and B (23 bp), were included to facilitate overlapping PCR ampliﬁca-
tions used for plasmid construction. The method to generate the
vector pDMGFloxPGUS by overlapping PCR ampliﬁcation is described
in the Materials and methods section.
Recombinant ASFV viruses were constructed by homologous
recombination between the MGF360 8L and MGF505 4R ﬂanking
regions of the transfected transfer vector DNA and the genome of
the ASFV virus isolate BA71V within infected Vero cells (Fig. 1).
Vero cells were infected with ASFV tissue culture adapted strain
BA71V followed by transfection with the transfer vector pDMG
FloxPGUS. After 48 h the virus was harvested and used to infect
fresh Vero cells and an overlay of 1% agarose applied. Seven days
following infection an additional overlay containing 100 mg/ml
X-Gluc was applied. Blue plaques containing ASFV recombinant
viruses expressing GUS were picked into DMEM media. The
frequency with which recombinant ASF viruses were generated
by homologous recombination was found to be approximately
one recombinant for every 5000 wild type virus progeny (data not
shown). Plaque puriﬁcation was repeated seven times until no
further ‘white’ wild type plaques could be observed on plates. The
isolated recombinant virus VDMGF-GUS was grown into high titreB FLANK  RGUS loxP
2089720236
FLANK RMGF 505 2R MGF 505 3R
20235
Homologous recombination
loxP B FLANK  RGUS
recombinase
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ous recombination between left and right ﬂanking regions (FLANK L and FLANK R)
ctor plasmid pDMGFloxPGUS resulting in the deletion of the truncated MGF360 9L
uences. A plasmid expressing the bacteriophage Cre recombinase protein under
F-GUS and second generation virus recombinant VDMGFDGUS was generated by
2GUS marker gene and single loxP site and the retention of a single loxP site. Non
FloxPGUS by overlapping PCR.
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and DNA sequencing to conﬁrm the insertion of the GUS marker
gene and loxP sites and deletion of the truncated MGF360 9L,
MGF505 2R and 3R genes (Fig. 2).
PCR analysis, using primers from within the virus genes MGF
360 8L and MGF505 4R ﬂanking the insertion site, identiﬁed the
expected the 3.2 kb fragment containing the truncated MGF360
9L, MGF505 2R and 3R genes in wild type virus BA71V (Fig. 2A
lane 1). From genomic DNA of recombinant virus VDMGF-GUS a
2 kb fragment was ampliﬁed, as expected, for the virus with MGF
505 2R and 3R genes replaced with the GUS marker gene cassette
(Fig. 2A lane 2). To conﬁrm that the recombinant virus VDMGF-
GUS contains the GUS gene, a PCR reaction was carried out with
an internal GUS gene primer RGUS and primer 8LSEQ from within
the MGF360 8L gene. The fragment ampliﬁed was the predicted
1.6 kb size (Fig. 2A lane 5). No PCR fragment was obtained with
BA71V as template (Fig. 2A lane 4) as BA71V does not contain a
GUS gene. To conﬁrm that the GUS marker gene had been inserted3.0 3.0
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Fig. 2. Generation of successive recombinant ASFV viruses Panel A. Analysis of genomic
type BA71V virus and the recombinant viruses VDMGF-GUS, VDMGFDGUS, VDMGFDC
PCR and the products were analysed by electrophoresis on 1% agarose gels. The
(8LSEQþRGUS), lanes 7–9 (EXT8LþRGUS), lanes 10–12 (152RSEQþ364RSEQ), lanes 13–
DNAs were used as templates in the lanes 1, 4, 7, 10, 13 and 16 (BA71V), lanes 2
(VDMGFDCD2vLectin-GUS), lanes 12, 15 and 18 (VDMGFDCD2vLectinDGUS). Lane M1
maps of BA71V (170101 bp) and the four recombinant viruses showing the positions of
positions 17725 and 20236. The two recombinant viruses VDMGFDCD2vLectin-GUS
EP402R genes located between positions 55,705 and 57,447. Recombinant viruses VDM
two loxP (P) sequences and viruses VDMGFDGUS and VDMGFDCD2vLectinDGUS showat the correct site within the genome of recombinant VDMGF-
GUS, a PCR reaction was carried out with a primer, EXT8L, located
in the MGF 360 8L gene but 50 external to the left ﬂank sequence
of transfer vector VDMGFloxPGUS. The results show that the
recombinant virus VDMGF-GUS (Fig. 2A lane 8) contains the
predicted fragment of 2.2 kb inserted in the expected location in
the genome. Analysis of samples from the BA71V parental
genome (Fig. 2A lane 7) showed no products were ampliﬁed with
primers EXTMGF and RGUS as was expected since BA71V does not
contain the GUS gene.
Removal of the GUS gene from recombinant VDMGF-GUS using the
Cre recombinase enzyme
To remove the GUS gene ﬂanked by loxP sites from the recombi-
nant VDMGF-GUS (Fig. 1), a plasmid, pVP72iCre, was constructed.
This contains the cre recombinase gene under the control of the ASFV
B646L (vp72) gene promoter (see theMaterials andmethods section).3.0
1.0
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viral DNA gene deletions and insertions by PCR. Viral DNA was extracted from wild
D2vLectin-GUS, VDMGFDCD2vLectinDGUS. Speciﬁc fragments were ampliﬁed by
following primer sets were used in the lanes 1–3 (8LSEQþ4RSEQ, lanes 4–6
15 (152RSEQþRGUS), lanes 16–18 (EXT152RþRGUS). The following viral genomic
, 5 and 8 (VDMGF-GUS), lanes 3, 6 and 9 (VDMGFDGUS), lanes 11, 14 and 17
contains a 1 kb DNA ladder and lane M2 a 100 bp DNA ladder. Panel B. Genomic
deletions of the truncated MGF360 9GL, MGF505 2R and 3R genes located between
and VDMGFDCD2vLectinDGUS show the additional deletion of the EP153R and
GF-GUS and VDMGFDCD2vLectin-GUS show insertion of the GUS gene ﬂanked by
deletion of the GUS gene retaining one copy of the loxP (P) sequence.
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cells were transfected with plasmid pVP72iCre. Three days after
infection, the virus was harvested and screened for ‘white’ recom-
binant viruses using the indicator X-Gluc as before. The frequency
with which the GUS gene was deleted by site-speciﬁc recombina-
tion by the Cre recombinase was determined to be approximately
one recombinant progeny viruses for every ten ‘wild type’ virus
(data not shown). This is a signiﬁcantly higher recombination rate
compared to the homologous recombination rate observed to delete
the MGF505 2R and 3R genes. Following three rounds of plaque
puriﬁcation the recombinant virus VDMGFDGUS was grown up to
high titre and genomic DNA isolated.
To conﬁrm deletion of the GUS gene from recombinant VDMGF
DGUS, PCR was used with virus genomic DNA as template. The
results in Fig. 2A show that using primers from the ﬂanking genes
MGF360 8L and MGF 505 4R a fragment of about 0.23 kb was
ampliﬁed (Fig. 2A lane 3). This was about 1.8 kb smaller than the
2.0 kb fragment ampliﬁed from the genome of VDMGF-GUS virus
(Fig. 2A lane 2) and conﬁrmed that the GUS reporter cassette had
been deleted as expected from VDMGFDGUS (Fig. 2A lane 3)
compared to the parental virus VDMGF-GUS (Fig. 2A lane 2).
Additional conﬁrmation that the GUS gene had been deleted from
VDMGFDGUS is shown in Fig. 2A lanes 6 and 9, which show that
no PCR fragment was ampliﬁed from the recombinant VDMGF
DGUS using an internal GUS gene primer RGUS and the primers
8LSEQ, EXT8L, respectively.
To conﬁrm the sequence at the sites of recombination within
the recombinant viruses VDMGF-GUS and VDMGFDGUS, DNA
fragments were ampliﬁed by PCR from virus genomic DNA using
the primers 8LSEQ and 4RSEQ from genes MGF360 8L and MGF
505 4R which ﬂank the insertion sites. These fragments were
cloned into the vector pCDNA3. Sequencing of the junctions
(Fig. 3) revealed that in recombinant virus VDMGF-GUS the GUS
gene had been inserted preceded by the non-viral A sequence
(21 bp), a loxP sequence (34 bp) and B646L (vp72) promoter
(39 bp). In the recombinant derived from this virus VDMGFDGUS,
analysis of the sequence conﬁrmed that the GUS gene had been
deleted along with one copy of loxP, leaving the sequence A
(21 bp), loxP (34 bp) and sequence B (23 bp). Thus the sequencing
conﬁrmed that the Cre recombinase had removed the vp72GUS
gene and one loxP site and that a single loxP site remained.
Having established that the recombinant virus VDMGF-GUS con-
tained a loxP site ﬂanking the 50 end of the vp72GUS gene (Fig. 3)
a PCR was carried out to conﬁrm that a second loxP site ﬂanked
the 30 end of the vp72 GUS gene. Primers from the GUS gene and
MGF505 4R genes generated a predicted fragment of 141 bp in aMGF3FLANK L
BA71V
ATTGAATG TTATATATCATTAAACCCATCATTAATATAGTGTTTATGTGCTA
VΔMGF GUS
loxPFLANK  L A
-
ATTGAATG GCGGGTACCGATGGATCCGCG ATAACTTCGTATAGCATACAT
ATTGAATG GCGGGTACCGATGGATCCGCG ATAACTTCGTATAGCATACA
loxPAFLANK L
VΔMGFΔGUS
Fig. 3. DNA sequence analysis of viruses BA71V, VDMGF-GUS and VDMGFDGUS at i
fragments from genomic DNAs spanning the insertion and deletion junctions between
and XhoI sites of pCDNA3. The fragments were sequenced with the 8LSEQ primer. Non v
sequences underlined indicate the MGF360 8L sequence, loxP sequence and non-viral se
FLANK R) are also indicated.PCR reaction conﬁrming the presence of a 34 bp loxP site (data
not shown).
Deletion of the EP402R and EP153R genes from recombinant virus
VDMGFDGUS
To conﬁrm that a gene deletion could be made at a second
locus on the BA71V genome using the GUS reporter gene, the
same homologous recombination process was used to delete the
EP402R and EP153R genes from virus VDMGFDGUS. This also
allowed the effect of this combination of gene deletions on virus
replication to be analysed. Since the EP402R and EP153R genes
are adjacent on the ASFV genome, they were deleted together.
Initially a transfer vector, pDCD2v-LectinloxPGUS (the Materials
and methods section), was constructed which contained the left
and right ﬂanking regions of the EP402R and EP153R genes from
genes EP152R and EP364R, respectively. The GUS gene under
control of the B646L ASFV gene late promoter and ﬂanked by loxP
sites and unique sites A and B was inserted between the ﬂanking
sequences as described in the previous section.
Vero cells were infected with the recombinant VDMGFDGUS
and transfected with the transfer vector pDCD2v-LectinloxPGUS.
The progeny viruses were harvested and recombinant viruses
expressing GUS were identiﬁed as forming blue plaques when
X-Gluc was added in the agarose overlay. Recombinant virus
VDMGFDCD2vLectin-GUS was plaque puriﬁed until no ‘white’
plaques could be observed. High titre stocks of virus were grown
and viral genomic DNA was isolated.
PCR was carried out using primers from the ﬂanking regions
152RSEQ and 364RSEQ. This ampliﬁed a 1.8 kb fragment from
virus VDMGFDGUS which is the size predicted for the fragment
containing the EP402R and EP153R genes (Fig. 2A lane 10). The
fragment ampliﬁed from recombinant VDMGFDCD2vLectin-GUS
was 2.0 kb, the size predicted for the deletion of the EP153R and
EP402R genes and replacement with the GUS gene cassette
(Fig. 2A lane 11). To conﬁrm that the recombinant virus
VDMGFDCD2vLectin-GUS contained the GUS gene a PCR reaction
was carried out with an internal GUS gene primer, RGUS, and
primer 152RSEQ. The results in Fig. 2 lane 14 show that the
predicted fragment of 1.6 kb was ampliﬁed from the genome of
recombinant virus VDMGFDCD2vLectin-GUS. To conﬁrm that the
GUS marker gene had been inserted at the correct site within the
genome of recombinant VDMGFDCD2vLectin-GUS a PCR reaction
was carried out with primer EXT152R. This primer is located in
the EP152R gene but is 50 external to the left ﬂank sequence of
transfer vector pDCD2v-LectinloxPGUS. The results show that the60 8L
TGGACAGGTTTTTTGAATGATAATCTTTTAACATACGTTTTATAA
VP72
TATACGAAGTTAT ACGAAGTTATATTTAATAAAAACAATAAATTTTTAT
TTATACGAAGTTAT TGGATCCAGCGGCCCGACGTACG GCGGTATGAT 
B FLANK R
nsertion site. The primers 8LSEQ and 4RSEQ were used to amplify by PCR DNA
the MGF360 8L and 9L and MGF 505 3R and 4R genes were cloned into the HindIII
iral sequences A and B were derived from the transfer vector pDMGFloxPGUS. The
quences A and B. Sequences of the ﬂanking genes to the left and right (FLANK L and
106
pf
u/
m
l
105
104
168
103
hours post infection
20 24 28 32
Fig. 4. Replication kinetics of wild type BA71V and recombinant viruses. Vero cells
were infected at a multiplicity of infection of 10 with parental BA71V strain or
recombinant viruses VDMGF-GUS, VDMGFDGUS, VDMGFDCD2vLectin-GUS,
VDMGFDCD2vLectinDGUS. At various hours post-infection, as indicated on the x
axis, total virus was harvested and infectious virus titrated by plaque formation on
Vero cells. The virus titre shown is the mean of triplicate samples. The titre
obtained is indicated in plaque forming units per ml (pfu/ml) on the y axis. Titres
obtained following infection with viruses BA71V&, VDMGF-GUSJ, VDMGFDGUS
þ , VDMGFDCD2vLectin-GUS D and VDMGFDCD2vLectinDGUS % are indicated.
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contains the predicted fragment of 2.8 kb. These primers did not
amplify a fragment from the BA71V genome (Fig. 2A lane 16) as it
does not contain a GUS gene.
Removal of the GUS gene from recombinant VDMGFDCD2v
Lectin-GUS using the Cre recombinase protein
Vero cells were infected with recombinant VDMGFDCD2v
Lectin-GUS, and then transfected with plasmid pVP72iCre. Several
days after infection, the virus was harvested from cell super-
natants and screened for recombinant viruses from which the
GUS gene had been deleted using the indicator X-Gluc as before.
Plaques which were not blue were picked. Following three rounds
of plaque puriﬁcation the recombinant virus VDMGFDCD2v
LectinDGUS was grown up to high titre and genomic DNA was
isolated.
To conﬁrm deletion of the GUS gene from recombinant
virus VDMGFDCD2vLectinDGUS, PCR with primers 152RSEQ and
364RSEQ was carried out with genomic DNA as template. The
results in Fig. 2A show that a fragment of 2 kb was ampliﬁed from
the genome of the virus VDMGFDCD2vLectin-GUS (Fig. 2A lane 11)
compared to a fragment of about 230 bp from the virus VDMGF
DCD2vLectinDGUS (Fig. 2A lane 12). Additional conﬁrmation that
the GUS gene has been deleted from VDMGFDCD2vLectinDGUS
is shown in Fig. 2A lanes 15 and 18, which show that no PCR
fragment is ampliﬁed from the genome with the internal GUS gene
primer RGUS and the two primers 152RSEQ and EXT152R,
respectively.
Deletion of the EP153R and EP402R genes in virus recombinant
VDMGFDCD2vLectin-GUS did result in changing the phenotype of
the virus to haemadsorption (HAD) negative, rendering the virus
unable to cause haemadsorption of pig red blood cells to Vero
infected cells (data not shown). This was expected since the
EP402R gene is essential for haemadsorption (Rodriguez et al.,
1993; Borca et al., 1994).
The ability of the different recombinant ASF viruses, VDMG
F-GUS, VDMGFDGUS, VDMGFDCD2vLectin-GUS, VDMGFDCD2v
LectinDGUS to replicate in Vero cells was, compared with the
parental BA71V strain by conducting a one step growth curve. Vero
cells were infected at high m.o.i. (10 pfu/cell) and titres of total
infectious progeny virus were determined at different time points
post-infection. The results in Fig. 4 showed that the four recombi-
nant viruses all replicated with similar kinetics and reached approxi-
mately the same titre as wild type BA71V. This showed that deletion
of the truncated MGF360 9L, MGF505 2R and 3R genes and EP153R
and EP402R genes or the insertion of the GUS marker gene ﬂanked
by loxP sequences do not signiﬁcantly alter the replication ﬁtness of
these recombinant viruses.
ASFV encodes a large number of genes which are not essential
for virus replication and these include genes encoding proteins
that modulate host defence pathways (Tulman et al., 2009). In
common with other large DNA viruses a number of proteins have
been described which target the same pathways, for example
several apoptosis inhibitors and more than one inhibitor of
phosphorylation of translation initiation factor eIF-2a have been
identiﬁed (Zhang et al., 2010) and several inhibitors of apoptosis
(Tulman et al., 2009). In order to understand the importance of
these pathways for virus replication a method which enables
sequential deletions of genes from the virus genome is required.
This is also an important tool for the construction of rationally
attenuated ASFV vaccines.
Here we describe a method to sequentially delete genes from the
ASFV genome making use of the cre/loxP recombination system to
remove the GUS marker gene from ﬁrst generation ASFV recombi-
nants so that the same marker can be used for additional deletions.Using this, a recombinant ASFV virus VDMGF-GUS was constructed
in which the MGF505 genes 2R and 3R and a truncated version of
MGF360 9L genes were ﬁrst deleted with the introduction of the GUS
marker gene ﬂanked by bacteriophage loxP sites. The GUS reporter
gene was then deleted by site–speciﬁc recombination at the two loxP
sites. This recombination was achieved at high efﬁciency (approxi-
mately 10% of virus progeny). Subsequently the samemarker cassette
was used to isolate recombinant virus VDMGFDCD2vLectin—
GUS with the EP153R and EP402R genes deleted in addition to the
previous deletion.
The cre/loxP site-speciﬁc recombination system from bacter-
iophage P1 (Sternberg and Hamilton, 1981) results in deletion of
DNA sequence located between two loxP sites oriented in the
same direction by the bacteriophage Cre recombinase. The 34 bp
loxP sites consist of an asymmetric 8 bp sequence ﬂanked by two
identical palindromic 13 bp sequences. The 343 amino acid Cre
recombinase protein belongs to the integrase family of enzymes
isolated from l bacteriophage P1. This site-speciﬁc recombination
system was ﬁrst used in mammalian cells by Sauer and
Henderson (1988). The cre/loxP bacteriophage recombination
system has been used previously to create HSV recombinant
viruses (Gage et al., 1992). However, these recombinant viruses
were initially generated in a cell free environment by Cre
recombinase induced integration of loxP containing plasmids into
the puriﬁed DNA genome of HSV, followed by the transfection of
genomic DNA into Vero cells before the isolation of HSV recom-
binant viruses. This method for generating recombinant viruses in
ASFV could not be used as ASFV genomic DNA is not infectious.
In this study a truncated gene MGF360 9L and two complete
MGF505 genes, 2R and 3R were deleted from the genome of the
tissue-culture adapted ASFV isolate BA71V. BA71V already has a
large deletion of 8 kb near the left end of the genome compared to
virulent ASFV isolates and lacks 5 complete members of MGF360
and 1 member of MGF505 encoded in this fragment by virulent
isolates (Chapman et al., 2008).
Previous studies have indicated that members of MGF360 and
MGF530 gene families have roles in macrophage cell tropism,
suppression of the type I interferon response and replication of
the virus in Ornithodoros spp. ticks (Zsak et al., 2001; Neilan et al.,
2002; Afonso et al., 2004; Burrage et al., 2004). The protein encoded
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tion of red blood cells to infected macrophages and extracellular
virions (Rodriguez et al., 1993), and has roles in inhibiting prolif-
eration of lymphocytes in response to mitogens and virus replica-
tion in ticks (Borca et al., 1998; Rowlands et al., 2009). The EP153R
protein is a C-type lectin domain containing protein which resem-
bles NK cell receptors and has been reported to inhibit up-regula-
tion of MHC-Class I expression on infected cells and inhibit
apoptosis (Hurtado et al., 2011). Deletion of these MGF505 2R and
3R genes in recombinant virus VDMGF-GUS and the further dele-
tion of the EP153R and EP402R genes in recombinant virus
VDMGFDCD2v
Lectin-GUS did not signiﬁcantly alter the growth characteristics of
these viruses compared to wild type BA71V.
In this paper we have described the efﬁcient sequential deletion
of speciﬁc genes from the genome of tissue culture adapted strain
BA71V using the bacteriophage cre/loxP recombination system. In
the future, this technology could be applied to manipulate the
genomes of ﬁeld strain ASF viruses to create attenuated vaccine
strains of ASFV. The generation of recombinant ASF ﬁeld viruses
with multiple gene deletions will be achieved by the infection and
transfection of isolated pig bone marrow macrophages in vitro. In
addition, the cre/loxP technology could be used for the efﬁcient
introduction of mutated ASFV genes into the ASFV genome in order
to study individual gene function.Materials and methods
Viruses and cell culture
Vero cells were grown in Dulbecco’s modiﬁed Eagle’s media
(DMEM) containing 10% FCS, glutamine 2 mM, penicillin and
streptomycin (10,000 u mg1ml1). Tissue culture adapted ASFV
strain BA71V and the recombinant ASF viruses VDMGF-GUS,
VDMGFDGUS, VDMGFDCD2vLectin-GUS and VDMGFDCD2v
LectinDGUS were propagated and titrated on Vero cells (Enjuanes
et al., 1976).
Construction of plasmid transfer vectors
The plasmid transfer vector pDMGFloxPGUS was constructed
to facilitate the deletion of genes MGF505-2R and MGF505-3R
from the genome of virus BA71V as shown in Fig. 1. Using BA71V
genomic DNA as template, a 727 bp fragment (Flank L) located in
the MGF360 8L gene at position 16,351–17,056 upstream of the
truncated MGF 360 9L gene and MGF505-2R gene was ampliﬁed
using the PCR primers LFMGF (GCGCAAGCTTGCTATGGCATAC-
CAGTATTTAACG) and LRMGF (CGCGGATCCATCGGTACCCGCCAT-
TAATATATGGATTGACATG). This left hand ﬂank fragment also
contained a non viral sequence A at the 30 end to facilitate further
overlapping PCR. A 681 bp fragment (Flank R) located in the
MGF505 4R gene at position 20,236–20,897 downstream of the
MGF505 3R gene was ampliﬁed using the PCR primers RFMGF
(TGGATCCAGCGGCCCGACGTACGGCGGTATGATGTACCCAATTG-
TAATG) and RRMGF (GCGCCTCGAGGCCATCTCAAACAATTCCT-
GATTCTCTCCC). This right hand ﬂank fragment also included a
non-viral sequence B at the 50 end. Two GUS gene fragments
AloxPvp72GUS (1390 bp) and GUSloxPB (680 bp) containing the
N- and C-terminal gene fragments, respectively, were ampliﬁed
from GUS gene template using the primer pairs ALOXPGUS
(GCGGGTACCGATGGATCCGCGATAACTTCGTATAGCATACATTA-
TACGAAGTTATATTTAATAAAAACAATAAATTTTTATAACATTATAT)
and RGUS (CCTTCTCTGCCGTTTCCAAATCGCCGC); FGUS (CGCGCC-
ACTGGCGGAAGCAACGCG) and BLOXGUS (ACTTACGTCGGGCCG-
CTGGATCCATAACTTCGTATAATGTATGCTATACGAAGTTATCATTGT-TTGCCTCCCTGCTGCGGTTTTTCAC). The AloxPvp72GUS fragment
contained the ASFV B646L gene promoter sequence fused up-
stream of the GUS gene start codon and upstream of this a single
loxP sequence and the unrelated sequence A to facilitate over-
lapping PCR ampliﬁcation. The GUSloxPB fragment contained a
single loxP site, in the same orientation as that in the AloxPvp72
GUS fragment, and an unrelated sequence B, downstream from
the GUS gene stop codon. In the second stage, overlapping PCR
was used to generate two separate DNA fragments. The ﬁrst
FlankLAloxPvp72GUS (2219 bp) was ampliﬁed by PCR from tem-
plates Flank L and AloxPvp72GUS using primer pair LFMGF and
RGUS. The second fragment GUSloxPBFlankR was ampliﬁed from
the PCR templates GUSloxPB and FlankR using primer pair FGUS
and RRMGF. A ﬁnal overlapping PCR reaction was carried out to
amplify the DNA fragment FlankLAloxPvp72GUSloxPBFlankR
using the templates FlankLAloxPvp72GUS and GUSloxPBFlankR
and the primer pair LFMGF and RRMGF. The 3.4 kb ampliﬁed
fragment was digested with Hind III and Xba I enzymes and
cloned into pCDNA3 plasmid vector digested with the same
enzymes to create transfer vector pDMGFloxPGUS. The structure
of the plasmid pDMGFloxPGUS was conﬁrmed by restriction
enzyme digestion (data not shown).
The plasmid transfer vector pDCD2v-lectinloxPGUS was con-
structed to delete the EP402R and EP153R genes, encoding the
CD2v and C-type lectin proteins. The same method as above was
used to construct the transfer plasmid pDCD2v-LectinloxPGUS
except different primers sets (LFCD2v GCGCAAGCTTCCTTGTTT-
TATTTATTATTATATACACCGC and LRCD2v CGCGGATCCATCGGTA-
CCCGCGATTAATTTTGTGTTATATATTTTTCAACCG) (RFCD2v TGGA-
TCCAGCGGCCCGACGTACGTCATGTATTTATTAAATACCACG and
RRCD2v GCGCCTCGAGCGCACACCATTTCCTTAGAAAAGCC) were
used to generate the upstream left ﬂank and downstream right
ﬂank fragments, respectively.
Construction of plasmid expressing Cre recombinase pVP72iCre
The 1070 bp DNA fragment containing the B646L gene pro-
moter sequence, ATTTAATAAAAACAATAAATTTTTATAACATTATAT,
upstream of the Cre recombinase gene was synthesised (Geneart,
Germany). The sequence of the cre recombinase gene was based
on the synthetic construct Pubmed Accession Number AY056050
but the nuclear localisation site was removed and the codon
usage optimised for mammalian gene expression. The 1070 bp
DNA fragment was digested with enzymes KpnI and SacI and
following ﬁlling of the ends to make them blunt-ended, was
cloned into the pCDNA3 vector digested with EcoRV to create
pVP72iCre.
Construction and isolation of recombinant ASF viruses
Vero cells (35 mm dish) at 75% conﬂuency were infected with
BA71V at a multiplicity of infection (m.o.i). of 10 and incubated at
37 1C for 5 h, and then washed with Dulbecco’s minimal essential
medium (DMEM). A transfection mixture containing 250 ml Opti-
mem (Gibco), 5 mg DNA transfer vector pDMGFloxPGUS or
pDCD2v-LectinloxPGUS and 7.5 ml TRANS-IT (Mirus) transfection
reagent was incubated at 20 1C for 20 min before adding it to the
infected cells. Incubation was continued at 37 1C for 4 h before the
addition of 1 ml DMEM and continued incubation at 37 1C. Virus
was harvested from the infected and transfected cells 48 h post-
infection. The harvested virus was used to infect 50% conﬂuent
Vero cells (100 mm dish) at a m.o.i. of 0.005 at 37 1C. Four hours
after infection the virus inoculum was removed and cells were
washed once in DMEM then a 1% Agarose/DMEM overlay contain-
ing 2% FCS was applied. Five days after infection a second overlay
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3-indolyl-b-D-glucuronic acid) was applied to the infected cells
and recombinant ASFV viruses were identiﬁed by the ‘blue’ appear-
ance of the plaques. Individual blue plaques were picked into 1 ml
DMEM and recombinant viruses were subjected to a further seven
additional plaque puriﬁcations until no ‘white’ plaques containing
wild type viruses could be observed. For removal of the GUS
reporter gene construct using cre recombinase, Vero cells were
infected with recombinant viruses expressing the GUS gene and
transfected with plasmid pVP72iCre expressing the Cre recombi-
nase. Progeny virus was harvested from culture supernatants after
3 days and used to infect Vero cells. Recombinant viruses from
which the GUS gene had been excised were identiﬁed as ‘‘white’’
plaques in the presence of overlay containing X-Gluc. and were
puriﬁed by plaquing until no ‘‘blue’’ plaques were observed.
Puriﬁcation and analysis of viral genomic DNA
Viral genomic DNA was puriﬁed from 300 ml virus containing
supernatants from infected cells using a GE Healthcare Illustra
genomic Prep Mini Spin kit. Analysis of viral genomic DNA was
carried out by PCR using the speciﬁc DNA primers 8LSEQ (CATGG-
TATAGAGAATATCATG), 4RSEQ (GATGTGGTCAAATAGTTAAG),
EXT8L (GATAGAAAAAGAAGATAGCTC), RGUS (CCTTCTCTGCCG
TTTCCAAATCGCCGC), 152RSEQ (CGCCACCGCACTAGGAAAAACG-
GTTG), 364RSEQ (GAAGACCAGCTTGAAACG) and EXT152R (GGTT-
GTGATGGTGCATGTAAC).
To conﬁrm the DNA sequence at the junction of recombination
sites, fragments of genomic DNA from wild type and recombinant
viruses were ampliﬁed using primers 8LSEQ and 4RSEQ and
cloned into plasmid pCDNA3 at the HindIII and XhoI sites. The
recombinant DNA junctions were sequenced using primer 9LSEQ
on an ABI Prism 373 DNA Sequencer and analysed using Chromas
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